MANCUSO, GAIA
MANCUSO, GAIA
Facoltà di Medicina e Chirurgia
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature
2021-01-01 Moroni, L.; Righini, P.; Ramirez, G. A.; Farina, N.; Mancuso, G.; Bozzolo, E.; Rodriguez-Pinto, I.; Cervera, R.; Nano, G.; Dagna, L.
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study
2022-01-01 Ramirez, G. A.; Lanzillotta, M.; Ebbo, M.; Fernandez-Codina, A.; Mancuso, G.; Orozco-Galvez, O.; Dagna, L.; Schleinitz, N.; Martinez-Valle, F.; Culver, E. L.; DELLA TORRE, Emanuel
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes
2020-01-01 Lanzillotta, M.; Campochiaro, C.; Mancuso, G.; Ramirez, G. A.; Capurso, G.; Falconi, M.; Dagna, L.; Della-Torre, E.
Colchicine as a new therapeutic option for antithyroid arthritis syndrome
2020-01-01 Mancuso, G.; Mancuso, G.; Boffini, N.; Dagna, L.; Dagna, L.; Della-Torre, E.
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study
2021-01-01 Della, Torre; Lanzillotta, M.; Campochiaro, C.; Di, Colo; Mancuso, G.; Capurso, G.; Falconi, M.; Dagna, L.
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients
2020-01-01 Rampi, A.; Lanzillotta, M.; Mancuso, G.; Vinciguerra, A.; Dagna, L.
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease
2021-01-01 Mancuso, G.; Jofra, T.; Lanzillotta, M.; Aiuti, A.; Cicalese, M. P.; di Colo, G.; Dagna, L.; Fousteri, G.; Della-Torre, E.
Urgent manifestations of immunoglobulin G4-related disease
2020-01-01 Della-Torre, E.; Mancuso, G.; Lanzillotta, M.; Ramirez, G. A.; Arcidiacono, P. G.; Capurso, G.; Falconi, M.; Dagna, L.
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease
2021-01-01 Della Torre, E.; Lanzillotta, M.; Germano, T.; Mancuso, G.; Ramirez, G. A.; Capurso, G.; Falconi, M.; Dagna, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature | 1-gen-2021 | Moroni, L.; Righini, P.; Ramirez, G. A.; Farina, N.; Mancuso, G.; Bozzolo, E.; Rodriguez-Pinto, I.; Cervera, R.; Nano, G.; Dagna, L. | |
| Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study | 1-gen-2022 | Ramirez, G. A.; Lanzillotta, M.; Ebbo, M.; Fernandez-Codina, A.; Mancuso, G.; Orozco-Galvez, O.; Dagna, L.; Schleinitz, N.; Martinez-Valle, F.; Culver, E. L.; DELLA TORRE, Emanuel | |
| Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes | 1-gen-2020 | Lanzillotta, M.; Campochiaro, C.; Mancuso, G.; Ramirez, G. A.; Capurso, G.; Falconi, M.; Dagna, L.; Della-Torre, E. | |
| Colchicine as a new therapeutic option for antithyroid arthritis syndrome | 1-gen-2020 | Mancuso, G.; Mancuso, G.; Boffini, N.; Dagna, L.; Dagna, L.; Della-Torre, E. | |
| Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study | 1-gen-2021 | Della, Torre; Lanzillotta, M.; Campochiaro, C.; Di, Colo; Mancuso, G.; Capurso, G.; Falconi, M.; Dagna, L. | |
| Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients | 1-gen-2020 | Rampi, A.; Lanzillotta, M.; Mancuso, G.; Vinciguerra, A.; Dagna, L. | |
| Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease | 1-gen-2021 | Mancuso, G.; Jofra, T.; Lanzillotta, M.; Aiuti, A.; Cicalese, M. P.; di Colo, G.; Dagna, L.; Fousteri, G.; Della-Torre, E. | |
| Urgent manifestations of immunoglobulin G4-related disease | 1-gen-2020 | Della-Torre, E.; Mancuso, G.; Lanzillotta, M.; Ramirez, G. A.; Arcidiacono, P. G.; Capurso, G.; Falconi, M.; Dagna, L. | |
| Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease | 1-gen-2021 | Della Torre, E.; Lanzillotta, M.; Germano, T.; Mancuso, G.; Ramirez, G. A.; Capurso, G.; Falconi, M.; Dagna, L. |